Walter Koroshetz, director of the National Institute of Neurological Disorders and Stroke, will soon be leaving his role, ...

The appointment of a fervent vaccine opponent — Robert F. Kennedy Jr. — as secretary of the Department of Health and Human ...

Brain-computer interface startups are surging — and poised to expand technologically and geographically. After early ...

Germany’s new ZB MED is “about ensuring that a single fragile pipeline doesn’t bottleneck good science,” experts write.

In this sector, news comes from research — on hair loss, smoking cessation, lupus, gonorrhea — and mergers and acquisitions.

More Americans will be exposed to foodborne illness as a result of this year's funding cuts, food safety experts predict ...

Democratic-led states and D.C. have sued HHS, calling an RFK Jr. declaration that rejected gender-affirming care an overreach ...

Last Thursday, the Trump administration released a proposed rule prohibiting hospitals that receive Medicare or Medicaid ...

For more than five years, pharma companies and PBMs have managed to avoid disclosing the actual prices of prescription drugs.

The health sector is working to navigate what could be the most significant changes to the U.S. vaccine program in decades.

The FDA has approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to ...

In less than a year, Kennedy has bulldozed vaccine policy precedent and government personnel. The Centers for Disease Control ...